Argan director sells 4,556 company shares
Argan Inc. director Jeffrey John Ronald Jr. reported an open-market sale of the company’s common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Argan Inc. director Jeffrey John Ronald Jr. reported an open-market sale of the company’s common stock. On March 31, 2026, he sold 4,556 shares at an average price of $539.85 per share, according to the filing footnote.
After this transaction, he directly holds 3,636 shares of Argan common stock and has an additional 8,000 shares held indirectly through an IRA account listed as “John R. Jeffrey, IRA.” No derivative securities are reported as outstanding in this filing.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 4,556 | $539.85 | $2.46M |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- F1. On March 31, 2026, the Reporting Person sold 4,556 shares of the Issuer's common stock on the open market at an average price of $539.85 per share.
Key Figures
Key Terms
open-market sale financial
Common Stock financial
indirect financial
IRA financial
transaction code "S" financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Argan Inc (AGX) disclose in this Form 4?
What are Jeffrey John Ronald Jr.’s remaining direct holdings in Argan Inc (AGX)?
Does the Argan Inc (AGX) director have any indirect holdings after the sale?
Were any derivative securities reported for Argan Inc (AGX) in this Form 4?
Was the Argan Inc (AGX) insider transaction classified as a buy or sell?
AI-generated analysis. How Rhea-AI works. Not financial advice.